Medidata and Fierce’s virtual workshop examines how coordinated travel and patient payments could reduce missed visits, protocol deviations and site workload.

Why logistics shape participation
Clinical trial logistics can affect whether participants enroll, attend visits and stay in a study. Data cited for integrated travel concierge support suggests screening rates could rise by as much as 50%, while protocol deviations could fall by up to two-thirds. Those figures describe potential gains, not guaranteed outcomes: the results of any support program can depend on the study, the participants it serves and how the services are delivered. Still, they point to a practical issue that trial teams can’t treat as peripheral. A study’s demands reach beyond its protocol and into the time, money and coordination required of the people taking part.
Travel is one part of that burden. Participants may need to arrange transportation, manage expenses and fit appointments around work, caregiving or other responsibilities. Payment is another part: when participants must pay costs upfront and wait for reimbursement, the delay can add pressure even if the expense is eventually covered. These tasks can appear manageable one by one, yet together they create friction. And the burden doesn’t fall only on participants; site staff may also spend time coordinating arrangements and resolving payment questions.
That’s the problem behind a virtual workshop hosted by Medidata and Fierce. The session will bring together speakers from pharmaceutical companies, clinical sites and patient advocacy to discuss linking study milestones with participants’ travel needs and payments. Its focus is the possibility that automated payments, paired with concierge travel services, could ease the participant experience, reduce site workloads and support retention across studies. The workshop’s premise is straightforward. Whether those benefits follow in practice is the question.
Connecting logistics to study needs
The workshop will cover ways to remove upfront travel expenses and reimbursement delays that can contribute to missed appointments and participant attrition. That framing matters because a missed visit can have several causes, and logistical support can address only some of them. A participant may have difficulty getting to a site, or may be dealing with constraints that travel assistance and payment timing don’t solve. The services are best understood as a way to reduce avoidable barriers, rather than as a cure for every reason someone might leave a study.
Linking support to study milestones could help teams coordinate services around when participants need them. In principle, that means planning travel and payments in relation to scheduled activities instead of asking participants or site staff to navigate separate processes on their own. The details will matter: the workshop is set to examine the approach, but the source material doesn’t specify how a platform would handle different study designs, participant preferences or unexpected changes. Those are operational questions, not minor implementation details.
The session will also examine support for protocol adherence, electronic patient reported outcome (ePRO) completion and patient trust. These topics connect logistics to the work of participating in a study. When processes are clear and practical, participants may find it easier to complete required activities; when they’re confusing or burdensome, even routine tasks can become another source of friction. That said, support services can’t guarantee adherence or trust. They can shape the experience around the study, while the quality of communication and the demands of the protocol remain part of the picture.
ePRO completion is a useful example of how seemingly separate parts of trial operations can meet. Participants may be asked to provide information electronically as part of their study activities, while also managing appointments and travel. Coordinating support around milestones could make those demands easier to navigate. It won’t remove the need for participants to complete the measures or for study teams to explain what’s expected. The potential value is in making the surrounding process more manageable.
What changes for clinical sites
For sites, automating workflows around study activities could reduce the time staff spend coordinating travel and handling payments. That time has an opportunity cost: staff attention is finite, and administrative tasks compete with other work involved in running a trial. A more coordinated process might give site teams fewer separate arrangements to track and fewer participant questions to resolve. But the size of any time saving will depend on how the service fits into existing operations and how much work it takes to manage exceptions.
The workshop will consider a shift from study by study arrangements to a unified platform approach for managing travel and payments. The attraction is consistency. If a site or sponsor has to handle the same kinds of tasks repeatedly across studies, a shared approach could make responsibilities and processes easier to organize. Yet a common platform also has to work for the particular needs of each study and its participants. A uniform process may simplify administration; it may also need room for different travel circumstances and payment requirements.
(And this is the part most people overlook.) Consolidating services doesn’t automatically remove complexity; it can move that complexity into the platform, its setup and the coordination between organizations. Someone still has to make sure participants understand the arrangements, staff know how to use the process and problems have a clear path to resolution. The workshop’s focus on pharmaceutical companies, sites and patient advocacy is relevant here, because the day-to-day experience depends on more than a software workflow. It depends on how the people involved work together.
For sites, the measure of success won’t be simply whether a travel service or payment system is available. It’ll be whether participants can use it when they need it and whether staff spend less time managing the surrounding work. A process that looks efficient on paper can still create extra steps if it’s hard to explain or poorly matched to site routines. The practical test is whether coordination improves without adding a new layer of administration.
What the approach could mean
The central question is whether coordinating payments and travel around study milestones can make participation easier while giving sites more capacity to focus on trial operations. This is more significant than it looks: logistics can influence the experience of a study without changing its scientific aims. If you’re working in this space, the useful question is where participants and site staff currently lose time or absorb costs, and whether linked support would address those specific points.
The cited figures offer a reason to examine the idea, but they shouldn’t be read as a promise that every study will see the same effect. Screening rates, protocol deviations and retention are outcomes shaped by many aspects of trial design and execution. Travel and payments may be part of the explanation for some difficulties, while other factors will sit outside the reach of a concierge service. The workshop can help frame the operational case; the source doesn’t provide enough detail to assess the evidence behind the figures or how broadly they apply.
That said, bringing payment and travel planning closer to study activities is a concrete proposition. It asks trial teams to treat participant logistics as part of operational planning, rather than as separate tasks to handle after the study is underway. The potential upside is less friction for participants and less coordination work for sites. The test is whether a unified approach can deliver both in the settings where trials actually run. Easier participation, if the services work as intended.
Discussion
Sign in to join the discussion.